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ABSTRACT 
 
 The spatiotemporal control of biological processes, especially cell growth and 
differentiation, remains one of the most compelling challenges in basic and clinical 
biomedical research. Fields as diverse as cancer therapy and regenerative medicine rely 
on spatial and temporal control of biochemical cues to achieve desired biological 
objectives. MicroRNA are attractive for highly-localized delivery applications because 
their instability in the cell restricts their biological effect to a small target area. These 
short, non-coding strands can be easily synthesized and modified for attachment and 
release from nanoparticle delivery vehicles. The research interest around microRNA 
therapies has produced a wide array of pathways dependent on microRNA, especially in 
osteogenesis, adipogenesis, and cancer therapy. The development of a versatile delivery 
platform will complement the wide array of microRNA pathways that are being 
discovered. The unique optical properties of metal nanoparticles provide a powerful tool 
for microRNA delivery via photochemical or photothermal methods. The plasmonic 
response of silver and gold particles provide an important complement to microRNAs 
with photocleavable linking moieties, where the coherent oscillation of electrons at 
specific wavelengths may be able to greatly enhance delivery efficiency while providing 
non-invasive external control of release.  
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1. INTRODUCTION 
 
1.1. Current Challenges in Gene Delivery 
 
Gene delivery has become one of the most prominent engineering challenges in 
biomedical research.1-11 As sequencing cost per genome plummets, as shown in Figure 
1.1, the “omics” fields continue a similar exponential trajectory. This rapidly growing 
field has yielded key discoveries in small regulatory RNAs and has led to an increasing 
number of gene targets being identified.12-16 Following this surge in identified targets and 
regulators, a new crop of synthetic oligonucleotide-based therapies will be entering 
testing in the decades to come, making the need to develop precisely controllable delivery 
vehicles even more urgent.4-6, 17-20  
 
Figure 1.1. Sequencing cost per human genome in comparison to Moore’s Law. Data is 
from the National Institute of Health’s National Human Genome Research Institute 
(graph available at genome.gov/sequencingcosts) 
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One of the most promising areas for gene therapy is the use of small non-coding 
RNA sequences, including small interfering RNA (siRNA)21-24 and microRNA (miRNA 
or miR).12, 25-27 As the volume of transcriptome analysis increases, it is becoming clear 
that these small RNAs are critical to posttranscriptional regulation of cellular processes.13, 
28 MiRNA have been found to be dysregulated in diseased tissues and may offer a means 
for “fingerprinting” disease at early stages.13-15, 25, 29-30 Perhaps even more exciting is the 
demonstrated role of these RNAs in the control of stem cell differentiation.12, 16, 27, 31-32 
This discovery holds broad implications in cancer biology and regenerative medicine, 
where the ability to control cell fate is a powerful tool.  
In particular, the challenge of engineering multiple cell types from a volume of 
undifferentiated cells demands precise spatiotemporal control of oligonucleotide delivery 
and release.26, 33-37 The development of new and improved delivery platforms to meet 
these and similar challenges will enable new ways to treat human disease and promote 
major advancements in regenerative medicine and synthetic biology. The highly localized 
nature of miRNAs, and their short lifetime in the cell, makes them an ideal candidate for 
controlling cell fate at extremely small scales.26, 31, 33 Combining the local effects of 
miRNA with nanomaterials provides the ability to use precisely targeted external stimuli 
such as light, heat, or magnetic fields to release miRNA in a controlled manner with high 
spatiotemporal resolution.23-24, 38-39 The ability to apply existing technologies such as 
magnetic resonance imaging or two-photon microscopy to gene therapy has the power to 
drive rapid clinical adoption of this technology, making high-resolution gene delivery a 
powerful tool for clinical medicine.  
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This thesis will describe at length why miRNA delivery from plasmonic 
nanoparticles (schematic in Figure 1.2) is a powerful tool for the spatiotemporal control 
of stem cell differentiation. Both miRNA and plasmonic nanoparticles are highly 
localized tools, owing to the degradation of the oligonucleotide40-41 and the small size and 
short-lived effect of the plasmon.42-46 The study of plasmonic nanoparticles for gene 
delivery is greatly enabled by second harmonic generation (SHG) spectroscopy, a 
powerful, surface-sensitive measurement technique, which is also described in detail.47-52 
Space in this thesis is also dedicated to future applications of miRNA-functionalized 
plasmonic nanoparticles in driving the differentiation of stem cells down multiple 
lineages in the same tissue volume.  
 
Figure 1.2. Illustration of light-activated miRNA-functionalized nanoparticle. 
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1.2. Potential Applications of MicroRNA Therapies 
 
MicroRNAs are short, noncoding strands of RNA that are responsible for 
postranscriptional control of gene expression.27, 53-54 MicroRNAs are produced by cells to 
control the expression of messenger RNA (mRNA) (illustrated in Figure 1.3).55 The 
partial or complete pairing of a miRNA strand with its mRNA complement, often in 
association with RNA silencing complexes, leads to degradation of the mRNA strand and 
reduction of protein translation for the target gene. In the case of differentiation, the 
miRNA-mediated knockdown of one pathway allows the endogenous signals from 
another pathway to drive the cell down that lineage.12-13, 27, 41 Continued study of these 
pathways has led some to propose that miRNAs could be master regulators of cell fate, 
making them key potential gene therapies.13, 33 
 
Figure 1.3. Illustration of miRNA origin and function. Briefly, primary miRNA are 
transcribed from DNA by RNA polymerase II (Pol II) or Pol III. This long transcript is 
folded into a single hairpin or multiple hairpins. Drosha and Pasha process the transcript 
into pre-miRNA, a 60-70 nucleotide stem-loop structure. Exportin 5 then transports the 
pre-miRNA out of the nucleus, where it is processed by the RNA enzyme Dicer and 
cleaved into a single 18-25 nucleotide strand. This single strand can then be incorporated 
into an RNA-silencing complex (RISC) to degrade post-transcriptional gene expression. 
Figure is from Jeffrey, 2008. 
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Despite composing an estimated 1% of the human genome, approximately one 
third of all genes are regulated by miRNA in some form.56-57 According to the database 
MiRBase.org,58 there have been 2,588 mature miRNAs sequenced as of June 2015. It is 
believed that many of these are nonfunctional, but an increasing number have been 
shown to control significant cellular processes including angiogenesis,38 osteogenesis,59 
adipogenesis,29, 31, 33, 60 and dendritogenesis,61 as well as the many related diseases and 
disorders.  
These oligonucleotides have significant appeal to biomedical engineers for 
several reasons. First, because they are single strands only approximately 22 nucleotides 
long, miRNAs are very easy to synthesize and modify for delivery. Thiolation provides a 
facile means of attachment to metal nanoparticles, and further modification can be done 
to include spacers, fluorophores, and photocleavable groups. Secondly, miRNAs have 
precise spatial and temporal activity in the cell, owing to their inherent instability and 
high natural turnover rate. This reduces the risk of uncontrolled diffusion that is common 
in some controlled release biologics like bone morphogenic protein, among others.62 
Lastly, the accelerating pace of miRNA discovery and pathway elucidation provides 
fertile ground for clinical applications of miRNA-based technologies, some of which are 
discussed in this thesis.  
1.3. Light-Activated Delivery Using Metal Nanoparticles 
 
Nanoparticle-based technologies have already made a substantial impact in 
biotechnology and medicine, with applications including biosensing, photothermal 
therapies, drug delivery, and programmed assembly.63-70 The three primary metallic 
nanoparticles used in medical applications – silver, gold, and iron oxide – are 
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biocompatible and offer unique optical, thermal, and magnetic properties that make them 
ideal candidates for gene delivery applications.71-76 While iron oxide particles are used 
mostly for applications involving magnetic resonance imaging,66, 77-79 silver and gold 
nanoparticles have been broadly used for delivery applications, with release mechanisms 
that include both internal stimuli like pH or enzymatic degradation and external stimuli 
like laser light or magnetic fields.10-11, 39, 80-83  
Our laboratory has previously combined existing photocleavable chemistries with 
modified miRNAs and attached them to silver nanoparticles. Using a UV-activated 
nitrobenzyl linker and the osteogenic miRNA-148b, our laboratory demonstrated that 
miRNA photorelease drives osteogenic differentiation in human adult adipose-derived 
stem cells (hASCs).81-82 Current efforts are directed towards enhancing release efficiency 
and developing other photocleavable moieties that offer more red-shifted cleavage peaks. 
This foundational work, along with the work done by other groups, indicates that 
photoactivated miRNA delivery is a powerful gene therapy tool.  
1.4. Second Harmonic Generation for Nanoparticle Delivery Systems 
 
Nonlinear laser spectroscopies such as second harmonic generation (SHG) are 
noninvasive and surface sensitive techniques that allow for precise measurements of 
surface events on colloidal nanoparticles.47, 84-86 For SHG to occur (illustration in Figure 
1.4), two incident photons of frequency 𝜔  add coherently to generate a photon of 
frequency 2𝜔. This frequency doubling is forbidden in bulk media, but SHG signal can 
be generated at surfaces and interfaces.47, 49-51, 87-89 Because the SHG signal is sensitive to 
both surface changes and local electric field, the release of highly charged 
oligonucleotides is an ideal candidate for SHG spectroscopy.   
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Figure 1.4. Illustration of SHG phenomena at the surface of functionalized nanoparticle. 
Inversion symmetry is broken at the nanoparticle interface, leading to the generation of 
SHG signal. 
1.5. Plasmonic Nanoparticles and Increasing the Efficiency of Delivery 
 
SHG allows for real-time measurement of photorelease in colloidal solution, 
providing a new level of detail to the characterization of nanoparticle delivery systems. 
This thesis will detail how photorelease kinetics can be quantified and the implications 
this has for the optimization and design of photoactivated nanoparticle systems. 
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Additionally, this thesis will present evidence from recent SHG studies that confirm that 
the plasmon of silver nanoparticles enhances nitrobenzyl photorelease. This discovery 
opens up a wide range of questions and applications for the field of gene delivery, many 
of which are covered in detail in the closing chapter.  
1.6. Nanoparticle Platforms for the Controlled Delivery of Multiple Genes 
 
One of the most interesting applications of plasmon-enhanced gene delivery could 
be differential gene delivery. While nitrobenzyl photochemistry limits photocleavage to 
365 nm light, our laboratory is developing photothermal chemistries that are wavelength 
independent and cleave at specific temperatures. This could allow for a system in which 
an osteogenic miRNA could be released from a silver nanoparticle when activated at 420 
nm, while an angiogenic miRNA could be released from a gold particle at 530 nm. This 
two input system would allow for precise spatiotemporal control of two genes in the same 
tissue volume.  
As previously mentioned, both miRNA and nanoparticle plasmons are inherently 
spatially and temporally limited, providing the possibility for high-resolution 
programming of multiple cell types in the same tissue volume. In addition, existing 
technologies such as two-photon microscopy already have the capability to achieve 
cellular and even subcellular resolution in thick tissue samples. Combining those 
advanced microscopy techniques with existing synthetic methods to produce core-shell 
silver and gold particles that are optically active in the near-infrared could provide a 
powerful clinical paradigm for regenerative medicine, reconstructive surgery, and a host 
of other applications. Key model systems, future experiments, and clinical applications, 
as well as alternative particle strategies will be providing in the final chapters.   
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2. MONITORING THE PHOTOCLEAVING DYNAMICS OF COLLOIDAL 
MICRORNA-FUNCTIONALIZED GOLD NANOPARTICLES USING 
SECOND HARMONIC GENERATION 
 
2.1. Introduction 
 
Short oligonucleotides including small interfering RNA (siRNA) and microRNA 
(miRNA) are involved in the post-translational control of gene expression and have 
become increasingly important in basic and applied biology.27, 53, 90-93 Because 
systemically administered siRNA and miRNA are rapidly degraded by RNases in the 
bloodstream before reaching their cellular targets, methods of protecting and delivering 
these oligonucleotides are important to the development of RNA-based therapeutics.23, 36, 
94-95 Thiolation of synthetic oligonucleotide strands and attachment to metal nanoparticles 
has become an important method to protect the oligonucleotide from enzymatic 
degradation and to facilitate transport into the cell.96-97 Our previous work has 
demonstrated that short nucleotide strands of antisense DNA81 and osteogenic miRNA-
148b59 are able to be attached to silver nanoparticles through thiol functionalization and 
then transported into mammalian cells, altering their fate after being released from the 
particle by photoactivation. Light activation presents a method with a greater potential for 
spatiotemporally controlled release than alternate methods based on chemical stimuli, pH, 
or ionic strength.21, 59, 98-100  
The unique optical properties of gold nanoparticles (GNPs), especially their 
activity in the visible and near-infrared regions, along with their biocompatibility and 
ease of synthesis, enable a number of applications including molecular sensing, labeling, 
drug delivery, and photothermal cancer treatment.11, 21, 98-100  The optical properties of 
GNPs are derived from the surface plasmon resonances which are characterized by the 
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coherent oscillation of free electrons under incident light.101-104 The plasmon resonances 
can cause significant optical field enhancements leading to processes such as surface 
enhanced Raman spectroscopy (SERS),105-106 surface enhanced fluorescence,107-108  and 
plasmon-exciton polariton resonant coupling.109 Gold nanoparticles having various 
geometries such as nanorods, nanocages, and nanoshells are attractive nanomaterials for 
optical contrast enhancement agents, cancer diagnosis, and therapeutics.110-112 Recent in 
vivo studies of oligonucleotide-functionalized GNPs have demonstrated their powerful 
ability for cancer gene therapy through controlled release.1, 113 GNPs can be 
functionalized with miRNA using the same thiolization method as silver nanoparticles 
and many other metallic nanoparticles.59, 81 To date, several groups have investigated 
light-activated nucleic acid delivery using GNPs to demonstrate the controlled release of 
DNA,98-99 the selective release of multiple DNAs,100 and light-activated gene silencing.11 
Here, we report the use of nonlinear spectroscopy to probe the nanoparticle 
surface during the process of oligonucleotide photorelease. Nonlinear laser 
spectroscopies such as second harmonic generation (SHG) and sum frequency generation 
are powerful, noninvasive, surface-sensitive techniques that are useful for the 
investigation of colloidal nanoparticles.52, 109, 114-115 In SHG spectroscopy, two incident 
photons of frequency 𝜔 add coherently to generate a photon of frequency 2𝜔. SHG is 
dipole forbidden in bulk media with inversion symmetry, but it can be generated from the 
surface and interfaces of nanoparticles where the inversion symmetry is broken.49, 87, 116 
The release of highly negatively charged miRNA from the surface of GNPs is an ideal 
candidate for SHG spectroscopy investigations. The SHG signal from this charged 
interface has two components given by the second-order susceptibility 𝜒 ! , which is 
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based on the two-photon spectroscopy, and the third-order susceptibility 𝜒(!), which is 
based on the electrostatic potential from the nanoparticle surface.88, 117-119 The SHG 
electric field 𝐸!"#  is proportional to the square root of SHG signal and is given by 𝐸!"# =   𝜒 ! 𝐸!𝐸! +   𝜒 ! 𝐸!𝐸!  Φ! , where 𝐸!  is the incident electric field of the 
fundamental laser at frequency ω and Φ! is the electrostatic surface potential. The 𝜒(!) 
term can be sensitive to any chemical change on the nanoparticle surface that causes a 
spectroscopic change at either 𝜔 or 2𝜔. The 𝜒(!) term depends on the net polarization of 
bulk molecules in the solvent which are induced by the electric field of the nanoparticle 
surface.89 
In this study, we demonstrate the applicability of SHG spectroscopy to light-
activated gene delivery by measuring the wavelength and power dependence of the 
kinetics associated with miRNA release from GNPs using nitrobenzyl photocleavable 
(PC) chemistry. The experimental setup uses a probe laser at 800 nm to generate SHG 
signals for real-time monitoring of the photorelease that is activated by a second 
wavelength-tunable and power-tunable laser. GNPs of 68 nm diameter are functionalized 
by a synthetic miRNA-148b that has been thiolated and modified with an ultraviolet-
active nitrobenzyl photocleavable group (schematic in Figure 2.1). SHG measurements as 
a function of irradiation time using different photocleaving laser wavelengths are 
conducted and compared to corresponding fluorescence quantification measurements and 
extinction spectra to investigate photocleaving efficiencies. Additionally, analysis of the 
photocleaving dynamics are monitored using time-dependent SHG measurements under 
different ultraviolet (UV) irradiation powers to better understand the kinetics of the 
photocleaving process.  
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Figure 2.1. Schematic representation of the PC-miRNA-148b functionalized gold 
nanoparticle attached with fluorophore 6-TAMRA. The nitrobenzyl photocleaveable 
group, between the spacer linker and the oligonucleotide, absorbs UV radiation centered 
at 365 nm to release the miRNA from the surface of the gold nanoparticle. 
2.2. Synthesis and Characterization of Gold Nanoparticles 
 
The colloidal gold nanoparticle sample of 68 nm diameter is prepared using a 
seeded-growth method where citrate is first used as a reducing agent and capping agent 
for the gold nanoparticle seeds followed by the addition of a stronger reducing agent, 
hydroquinone, to produce larger GNPs with low polydispersity. During the gold 
nanoparticle seed synthesis, 900 µL of 34 mM sodium citrate is added to 30 mL of 290 
µM gold chloride in ultrapure water under boiling conditions with vigorous stirring. The 
solution changes color to a bright red after 10 minutes and is then cooled to room 
temperature. In the second step, 150 µL of the seed solution is added to 2.9 mM of gold 
chloride in 10 mL of ultrapure water, followed by the addition of 100 µL of 0.03 M 
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hydroquinone and 22 µL of 34 mM sodium citrate. The solution is left to stir at room 
temperature for 60 min to produce the 68 nm colloidal gold nanoparticles. 
The surface of the gold nanoparticles are functionalized with fluorophore-labeled 
miRNA via a ‘salt-ageing’ technique as described previously.59 Here, 2.5 µL of 0.8 
µg/µL of the miRNA-148b (PC-miR-148b) modified with the thiolated photocleavable 
nitrobenzyl group and labeled with a 6-TAMRA fluorophore group is added to 1 mL of 
the gold nanoparticles at a concentration of 8.25 x 109 nanoparticles/mL. The mixed 
samples are left to incubate for 24 h under gentle agitation conditions. Following the 
incubation period, 10 µL of 0.035 M sodium dodecyl sulfate (SDS) solution and 20 µL of 
0.01 M phosphate buffer saline solution (PBS) solution are added to each sample. After 
an additional 3 h of incubation, a 10 µL solution of 2 M tris(hydroxymethyl) 
aminomethane (Tris) and 2 M NaCl  is added three times, with 3 h of incubation between 
each salting step. The miRNA-functionalized nanoparticles are purified via centrifugation 
three consecutive times at 7000 rpm for 20 min each. During the first two centrifugation 
cycles, the precipitate obtained from 1 mL of sample is resuspended in 1 mL of solution 
containing 0.035 M SDS, 0.1 M Tris, 0.103 M NaCl, and 0.0005 M disodium 
diphosphate, and finally in 1 mL of deionized water after the third centrifugation.  
The gold nanoparticles are characterized using transmission electron microscopy 
(TEM), dynamic light scattering, extinction spectroscopy, and zeta potential 
measurements. The average nanoparticle diameter is determined to be 68 ± 7 nm 
diameter from TEM measurements, with representative TEM images shown in (a) of 
Figure 2.2. Figure 2.2 (b) shows TEM images of GNPs after functionalization with 
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miRNA, where a very thin layer of approximately 2 nm in thickness is observed around 
the nanoparticles, showing the added functionalized miRNA. 
 
Figure 2.2. Representative TEM images of (a) gold nanoparticles and (b) gold 
nanoparticles functionalized with PC-miRNA-148b. 
Figure 2.3 displays the experimental extinction spectrum of the 68 nm GNPs in 
water (red line) with a localized surface plasmon peak centered on 543 nm, compared to 
the best fit from Mie theory (dashed gray line) at a concentration of 8.25 × 109 
nanoparticles/mL. Dynamic light scattering measurements determine the hydrodynamic 
diameter of the GNP sample to be 68 ± 15 nm, in agreement with the TEM and extinction 
spectroscopy results. The hydrodynamic diameter of the GNPs after functionalizing with 
miRNA increases to 140 ± 20 nm, due to the attached miRNA in solution.  
 
Figure 2.3. Extinction spectrum of the 68 nm colloidal gold nanoparticle sample in water 
(red line) compared with the best fit from Mie theory (dotted black line). 
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The zeta potential of the colloidal GNP sample before and after functionalization 
with miRNA is obtained from electrophoretic mobility measurements using the Huckel 
approximation.120 The electrophoretic mobility for the GNPs and the GNPs 
functionalized with miRNA is shown in Figure 2.4.  
 
Figure 2.4. Electrophoretic mobility plot of gold nanoparticles and miRNA functionalized 
gold nanoparticles showing the measured averages (dashed and solid black lines, 
respectively) and corresponding standard deviations (red and blue areas, respectively). 
The electrophoretic mobility of GNPs is measured to be (−2.65 ± 0.8) × 10−8 
m2/Vs with a corresponding zeta potential −50 ± 17 mV. The electrophoretic mobility of 
miRNA-functionalized GNPs is measured to be (−3.98 ± 0.9) × 10−8 m2/Vs with a 
corresponding zeta potential −76 ± 18 mV, where the highly-charged miRNA attached to 
the surface in aqueous solution increases the negative zeta potential. 
2.3. Experimental Setup 
 
The experimental setup for the second harmonic generation studies (schematic in 
Figure 2.5), is modified from a previously reported version.109 The setup uses a 
titanium:sapphire oscillator laser, a titanium:sapphire amplifier laser, an optical 
parametric amplifier (OPA) laser, an optical setup, and a high-sensitivity CCD 
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spectroscopy detector. The oscillator laser operates at a center wavelength of 800 nm 
with 75 fs pulses at a repetition rate of 80 MHz and an average power of 2.5 W. A 
beamsplitter separates the oscillator laser beam into one path that is used as the probe 
laser for the SHG measurements and another path that is used to seed the amplifier. A 
portion of the amplifier laser is sent through the OPA to generate the tunable UV or 
visible wavelengths with 100 fs pulses at a repetition rate of 10 kHz.  
 
Figure 2.5. Experimental setup showing the UV beam (blue) and 800 nm probe (red) 
beam, which are focused to the colloidal nanoparticle sample in a 1 cm quartz cuvette, 
with the SHG signal detected using a spectroscopy CCD detector. 
The 800 nm probe laser beam for SHG measurements is attenuated to an average 
power of 790 mW and focused to the colloidal sample, which is contained in a 1 cm by 1 
cm quartz cuvette at a concentration of 8.25 ×109 nanoparticles/mL in water with the 
SHG collected in the forward direction. The wavelength-tunable visible or UV beam for 
photoactivation is directed to the nanoparticle sample at 90° with respect to the 800 nm 
beam. The SHG from the nanoparticle sample is measured as a function of the UV laser 
irradiation time for investigating photocleaving reaction dynamics from the miRNA-
functionalized GNPs. A beam block opens and shuts on the photocleaving UV beam 
every 30 seconds in synchronization with an automated file-saving program so that the 
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SHG can be measured in real time to monitor the photoactivated drug-delivery reaction. 
A variable neutral density filter is used to control the power of the UV laser. Automated 
stirring is initiated during the UV laser irradiation and is stopped when the UV laser is 
blocked for stable SHG measurements, which are collected at multiple 1 second 
acquisitions for statistical analysis. 
2.4. Results and Discussion 
 
The light-activated controlled release of oligonucleotides from the surface of gold 
nanoparticles is monitored in real time using second harmonic generation. Representative 
SHG spectra of the GNPs and the miRNA-functionalized GNPs are shown in (a) of 
Figure 2.6 under the same 800 nm laser conditions and nanoparticle concentrations. The 
SHG peak is centered at 400 nm with a full width half maximum of 4.5 nm. The slight 
rise in signal at longer wavelengths is due to the two-photon fluorescence from the GNPs. 
The larger SHG signal from the miRNA-functionalized GNP sample compared to the 
GNP sample arises primarily as a consequence of the highly-charged miRNA leading to a 
higher electrostatic surface potential magnitude and a larger 𝜒(!) term in the SHG field 
equation, although some added contribution may also result from an increased 𝜒(!) term. 
The 6-TAMRA fluorophore label attached to the miRNA is chosen for corresponding 
fluorescence quantization measurements, while having minimal absorption at either 800 
nm or 400 nm, where no added fluorescence is observed in the SHG spectra so the 
fluorophore is expected to have negligible SHG contribution. Figure 2.6 (b) displays the 
SHG spectra of the miRNA-functionalized GNPs exposed to different UV irradiation 
times of 0 s, 30 s, and 90 s using 365 nm at 85 mW. As the UV irradiation time increases, 
the SHG intensity decreases and asymptotically approaches a minimum value. The 
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decrease in SHG intensity as a function of UV laser irradiation time is due to the change 
in the surface structure and surface charge leading to a change in the corresponding 𝜒(!) 
and 𝜒(!) terms upon photocleaving. The change in the 𝜒(!) term is expected to be the 
dominant contribution to the change in the SHG signal due to the loss of the high-charged 
miRNA upon photocleaving. 
 
Figure 2.6. (a) SHG spectrum of colloidal miRNA-functionalized gold nanoparticle 
sample compared with SHG spectrum of gold nanoparticles only. (b) SHG spectra of 
miRNA- functionalized colloidal gold nanoparticle sample after different UV irradiation 
times using 365 nm with 85 mW average power. The probe laser is fixed at 800 nm.  
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Figure 2.7 (a) displays results from control experiments which show the SHG 
signal from GNPs and miRNA-functionalized GNPs as a function of time. The SHG 
signal for the miRNA-functionalized GNPs is shown to remain constant over time when 
using the 800 nm probe laser only (triangle data points). Additionally, the SHG signal 
from the GNPs is shown to remain constant over time when using both the 800 nm probe 
laser and the UV laser at 365 nm and 20 mW average power (circle data points), while 
maintaining a much lower SHG signal than the miRNA-functionalized GNPs. However, 
the SHG signal from the miRNA-functionalized GNPs decreases as a function of time 
and asymptotically approaches a minimum value when using both the 800 nm probe laser 
and the UV laser at 365 nm and 20 mW average power (square data points) due to the 
photocleaving dynamics. The asymptotic minimum value of the miRNA-functionalized 
GNPs after UV irradiation is approximately equal to the SHG signal of the GNPs, 
indicating the miRNA-functionalized GNPs has the roughly same SHG signal as the 
GNPs after photocleaving is complete. This real-time monitoring of photocleaving 
dynamics is investigated under varying UV laser wavelengths and powers, and the 
photocleaving results are verified using extinction spectroscopy and fluorimetry 
measurements. 
Figure 2.7 (b) shows a wavelength-dependent study on the photocleaving 
dynamics of miRNA from the nanoparticle surface. When the sample is irradiated with 
the UV laser at 365 nm, which is on resonance with the PC linker, there is a fast decay of 
the SHG signal, corresponding to a fast rate of photocleaving and a large release of 
miRNA. The decay rate of the SHG signal decreases when the UV wavelength is off 
resonance compared to the PC linker, resulting in a slower rate of photocleaving and 
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nucleotide release. The time-dependent SHG intensity under the UV irradiation 
wavelengths of 330 nm, 375 nm, and 415 nm results in slower rates of photocleaving in 
comparison to the 365 nm results, while irradiation at 500 nm and 300 nm does not 
produce any measurable photocleaving. The UV laser power is kept constant at 20 mW 
for direct comparison of the photocleaving rate at all of these wavelengths 
 
 
Figure 2.7. (a) The SHG signal remains constant in time for both the miRNA-
functionalized GNPs using the 800 nm probe laser only (triangle data) and the GNPs 
using the 800 nm probe and the UV laser at 365 nm (circle data). The SHG decreases as a 
function of time when the miRNA-functionalized GNPs are irradiated with the UV laser 
at 365 nm (square data).  (b) Time-dependent SHG measurements show the 
photocleaving dynamics of miRNA from the surface of gold nanoparticles using different 
UV and visible laser wavelengths at 20 mW average power.  
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In order to quantify the photocleaving dynamics, a simple model is described. 
SHG is understood to be a coherent process from the surface of each individual colloidal 
nanoparticle, while the overall SHG signal is the incoherent sum of the SHG signal from 
each nanoparticle in the probe laser focus such that the SHG signal is linearly 
proportional to the nanoparticle concentration.49, 114 Therefore, using the results from (a) 
of Figure 2.8, the SHG electric field can be expressed using the equation 𝐸!"# = 𝐴 +𝐵[𝐶], where 𝐴 is an offset that includes background signal and the SHG from GNPs, [𝐶] 
is the cumulative concentration of attached miRNA on the GNP surface, and 𝐵 is a 
proportionality constant. If we assume a single UV photon causes photocleaving from a 
single miRNA attached to the GNP surface with an associated equilibrium constant 𝑘, 
then the change in [𝐶] with respect to time 𝑑[𝐶] 𝑑𝑡 is equal to −𝑘[𝐶][ℎ𝜈], where [ℎ𝜈] is 
the concentration or intensity of UV light. Under constant UV irradiation intensity, the 
time dependence of [𝐶] should follow an exponential decay given by 𝐶 𝑡 =    𝐶 !𝑒!!!! 
where 𝐶 ! is the initial concentration of attached miRNA on the GNP surface and 𝑘! = 𝑘[ℎ𝜈]. Notice that the pseudo first-order rate constant 𝑘! is linearly proportional to 
the UV light intensity. Under this simple model, assuming the photocleaving occurs 
through a one-photon process, the SHG electric field, which is proportional to the square 
root of the SHG signal, is expected to decay exponentially as a function of UV irradiation 
time, with a rate constant that is linearly proportional to the UV laser power.  
In order the test the accuracy of this model, the kinetics of the photocleaving 
process for miRNA-functionalized GNPs are studied using different UV laser powers 
centered at 365 nm. The measured time-dependent SHG electric field from colloidal 
miRNA-functionalized GNP sample under varying UV laser powers is shown in (a) 
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Figure 2.8. Each set of results are fit to a pseudo first-order exponential decay, as 
explained above, for UV laser powers of 35 mW, 45 mW, 55 mW, 75 mW, and 85 mW, 
respectively, to obtain the rate constants 𝑘! of (4.57 ± 0.4) × 10−3 S−1, (6.44 ± 0.4) × 10−3 
S−1, (7.6 ± 0.8) × 10−3 S−1, (9.71 ± 0.6) × 10−3 S−1, and (11.2 ± 0.7) × 10−3 S−1, 
respectively. Figure 2.8 (b) displays these measured rate constants as a function of UV 
laser power. The linear best fit is given by a slope of (1.26 ± 0.07) × 10−4 S−1mW−1 and a 
y-intercept of is (4.7 ± 4.5) × 10−4 S−1 and is in excellent agreement with the data, 
verifying that the photocleaving associated with the miRNA-functionalized GNPs is a 
one-photon process.  
 
Figure 2.8. (a) Measured SHG electric field from miRNA-functionalized GNPs as a 
function of irradiation time with 365 nm at different UV laser average powers with 
corresponding exponential fits. (b) The obtained rate constants are plotted as a function of 
UV laser power. The linear variation as a function of laser power indicates a one-photon 
process. 
The laser-assisted controlled release of miRNA from the surface of GNPs is 
further analyzed using extinction spectroscopy measurements. Figure 2.9 shows a 
significant shift in plasmon peak of the GNPs from 543 nm to 553 nm after 
functionalization with nucleotides. The extinction spectra is blueshifted after UV laser 
irradiation of the sample compared to the original miRNA-functionalized GNP sample. 
These results further indicate that the oligonucleotides are releasing from the surface of 
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GNP upon the UV laser irradiation. Analysis of these measurements demonstrates that 
the extinction spectrum of colloidal GNPs closely matches the extinction spectrum of the 
miRNA functionalized GNP sample after irradiation at 20 mW of 365 nm for 13 min, 
with the plasmon peak blueshifting back to 543 nm. At longer UV irradiation 
wavelengths of 375 nm and 390 nm, under 20 mW for 13 min there is less blueshift in the 
extinction spectra compared to the miRNA-GNPs, going back to plasmon peaks of 545 
nm and 548 nm, respectively, indicating incomplete photocleaving of the miRNA from 
the gold nanoparticle surface.  
 
Figure 2.9. The extinction spectra of colloidal miRNA-functionalized gold nanoparticles 
after irradiating at different UV laser wavelengths. The extinction spectrum of the 
miRNA- functionalized GNPs is redshifted with respect to the spectrum of GNPs only. 
After photocleavage with UV laser irradiation, all spectra are blueshifted compared to the 
miRNA-functionalized GNPs. 
The amount of miRNA released from the surface of the nanoparticles is quantified 
using fluorescence measurements. For comparison, the concentration of miRNA 
molecules on the surface of the GNPs are first quantified using fluorescent-plate readings 
after chemical detachment of the miRNA. A volume of 10 µL of 65 mM of dithiothreitol 
(DTT) is added to 1 mL of the gold nanoparticles to reduce the miRNA, followed by 
agitation and 20 min of incubation at 37 °C for complete chemical cleavage of the 
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oligonucleotides. The samples are then centrifuged at 7000 rpm and three separate 100 
uL aliquots of the supernatant are transferred to a 96-well plate for each sample. The 
concentration is then determined from a constructed standardized curve of the 6-TAMRA 
fluoro group that is attached to the end of the miRNA.59  The oligonucleotide coverage 
for nanoparticles is determined to be 92 ± 21 oligo/nanoparticle, yielding a surface 
density of (6.30 ± 1.48) x 1011 oligo/cm2. The amount of miRNA released during DTT 
reduction and after irradiation with 20 mW average power for the different UV laser 
wavelengths of 365 nm, 375 nm, and 390 nm, respectively, for 13 min is shown in Figure 
2.10. Photocleaving is shown to be most efficient at 365 nm on resonance with the 
nitrobenzyl group, in agreement with the time-dependent SHG measurements. The 
corresponding extinction spectroscopy and fluorimetry measurements all agree with the 
general description provided by the SHG results, demonstrating a consistent 
interpretation of the photoactivated controlled release of oligonucleotides from the gold 
nanoparticle surface. 
 
Figure 2.10. Fluorescence measurements of the supernatants of the miRNA-
functionalized GNPs after chemical reduction with DTT and after 13 min of UV 
irradiation using 20 mW of 365 nm, 375 nm, and 390 nm wavelengths, respectively. 
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2.5. Conclusion  
 
Second harmonic generation is used to monitor the photo-activated controlled 
release of miRNA from the surface of colloidal gold nanoparticles. The SHG signal is 
seen to significantly decrease as a function of UV laser irradiation time, with larger 
photocleaving rates occurring at higher UV laser powers on resonance with the 
nitrobenzyl linker, according to a single-photon photocleaving process. The 
photocleaving dynamics are in excellent agreement with a model using a pseudo first-
order rate equation. Corresponding extinction spectroscopy shows a redshift in the 
plasmon resonance peak after functionalizing the GNPs with miRNA and a blueshift after 
illumination with the UV laser, supporting the interpretation from the time-dependent 
SHG results. Fluorescent measurements also indicate that the miRNA is completely 
removed following UV laser irradiation. These results demonstrate the successful 
application of sensitive real-time measurements of photo-activated drug delivery using a 
model system of colloidal miRNA-functionalized gold nanoparticles in water. 
2.6. Materials and Methods 
 
2.6.1. Chemicals and Reagents 
 
For the synthesis of gold nanoparticles, high purity chemicals are purchased from 
Sigma Aldrich, including gold (III) chloride hydrate (99.999%), sodium citrate dihydrate 
(≥ 99%) and hydroquinone (≥ 99%). Ultrapure water having resistivity of >18.2 MΩ is 
used during the synthesis and spectroscopic measurements. Custom thiol-functionalized 
miRNA-148b is purchased from Trilink Bio Technologies. The PBS solution, sodium 
chloride solid, and dithiothreitol are purchased from Sigma Aldrich. 
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Diethylpyrocarbonate (DEPC) water is purchased from Ambion, sodium dodecyl sulfate 
(SDS) from VWR, and tris(hydroxymethyl) aminomethane from Amresco.   
2.6.2. Characterizations of Gold Nanoparticles 
 
The dynamic light scattering and electrophoretic mobilities of the colloidal gold 
nanoparticle samples are obtained using a Malvern Zetasizer (Nano series, Malvern 
Instruments Inc., USA). TEM images of nanoparticles before and after functionalization 
with miRNA are obtained using a high resolution JEOL JEM-2011 scanning TEM 
equipped with a Gatan SC1000 CCD camera and an EDAX EDS. Extinction 
measurements are acquired using a Perkin Elmer Lambda 35 UV-Vis spectrophotometer. 
2.6.3. Second Harmonic Generation Setup 
 
The ultrafast laser systems used in this study include a Chameleon oscillator laser, 
a Legend Elite amplifier laser, and a TOPAS tunable optical parametric amplifier, which 
are all purchased from Coherent Inc. The signal detection is achieved using a 
spectrograph/monochromator (Acton SP2300) and CCD detector (PIXIS 400) purchased 
from Princeton Instruments. 
2.6.4. PC-miR-148b Quantification 
 
Oligonucleotide coverage of the gold nanoparticles are quantified using 
fluorescence spectroscopy and inductively coupled plasma optical emission spectroscopy 
(ICP-OES) measurements. PC-miR-148b oligonucleotides from the surface gold 
nanoparticles are cleaved using 1% DTT and the tunable laser irradiation as mentioned 
above. After centrifugation, the supernatant is quantified with fluorimetry using a Wallac 
VICTOR2 V1420-040 Multilabel Counter (Perkin-Elmer, Boston, MA, USA) at 
excitation and emission wavelengths of 531 nm and 572 nm, respectively. The 
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concentration of oligonucleotides is calculated using a standardized curve over various 
concentrations of PC-miR-148b. The gold nanoparticle content is quantified using ICP-
OES (Varian, Palo Alto, CA, USA) after dissolving in 1.6 M nitric acid. 
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3. PLASMON-ENHANCED PHOTODELIVERY OF MICRORNA USING 
SILVER NANOPARTICLES 
 
3.1. Introduction 
 
Plasmonics has become one of the fastest growing fields of physics, with 
applications ranging from solar energy to quantum optics.67, 121-125 Of particular interest in 
biomedicine is the application of plasmonics to biosensing and photothermal therapy. 
Plasmonics has played a role the development of label-free assays, which have become 
widely used in studying protein binding events. Tools like surface enhanced Raman 
spectroscopy (SERS) and surface plasmon resonance (SPR) imaging have become 
invaluable tools in biotechnology.45, 63-64, 126-127 Photothermal therapy uses light activation 
of nanoparticles to produce heat near the nanoparticle surface. By functionalizing the 
nanoparticle surface with antibodies or other targeting molecules, this heating can be 
used to selectively kill diseased cells. This has become a very important tool in cancer 
therapy, where photothermal therapy is also used to enhance the permeability of tumors 
to certain chemotherapeutic agents, reducing the concentration of drug in the surrounding 
healthy tissue.42, 44, 128-133 
The localized and time dependent nature of nanoparticle plasmons have also made 
them of interest in drug delivery, where plasmons could provide a catalytic effect on the 
photochemical or photothermal reactions that drive release. Precedence for plasmonic 
catalysis exists in certain oxidation and reduction reactions in both silver and gold 
surface-supported constructs.134-137 The first instance of plasmonic catalysis involved the 
reduction of p-aminothiophenol (PATP) to 4,4-dimercaptoazobenzene (DMAB). This 
reaction has been shown to be catalyzed by surface-supported gold and silver plasmons at 
their respective peak wavelengths, indicating that the energy from the plasmon is 
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necessary for the reaction to reach its activation barrier.138 Changing the support material 
to TiO2 and adding a UV illumination source caused the reduction product of PATP to be 
p-nitrophenol (PNTP), which was subsequently reduced to DMAB upon removal of UV 
irradiation. Other groups have demonstrated that plasmon catalysis is possible in colloidal 
solution. Further, it has been demonstrated that these mechanisms may proceed via 
plasmon participation in electron transfer. Finally, two broad classes of plasmon catalysis 
have been proposed – electron-mediated photocatalysis and phonon-mediated thermal 
catalysis.134-135, 137-142  
This work demonstrates the plasmon-enhanced photorelease of miRNA from 
silver nanoparticles. The kinetics of nitrobenzyl photocleavage were compared for 
similarly sized gold and silver nanoparticles using second harmonic generation 
spectroscopy (SHG). In SHG spectroscopy, two incident photons of frequency 𝜔 add 
coherently to generate a photon of frequency 2𝜔. SHG is dipole forbidden in bulk media 
with inversion symmetry, but it can be generated from the surface and interfaces of 
nanoparticles where the inversion symmetry is broken.49-50, 85, 88-89 The release of highly 
negatively charged miRNA from the surface of nanoparticles is an ideal candidate for 
SHG spectroscopy investigations. The SHG signal from this charged interface has two 
components given by the second-order susceptibility 𝜒 ! , which is based on the two-
photon spectroscopy, and the third-order susceptibility 𝜒(!) , which is based on the 
electrostatic potential from the nanoparticle surface. The SHG electric field 𝐸!"#  is 
proportional to the square root of SHG signal and is given by 𝐸!"# =   𝜒(!)𝐸!𝐸! +  𝜒(!)𝐸!𝐸!  Φ!  , where 𝐸!  is the incident electric field of the fundamental laser at 
frequency ω and Φ! is the electrostatic surface potential. The 𝜒(!) term can be sensitive 
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to any chemical change on the nanoparticle surface that causes a spectroscopic change at 
either 𝜔 or 2𝜔. The 𝜒(!) term depends on the net polarization of bulk molecules in the 
solvent which are induced by the electric field of the nanoparticle surface.49, 85, 88, 114-115 
The plasmon of silver nanoparticles is shown to interact with the 365 nm cleavage 
wavelength of the nitrobenzyl group, demonstrating an improvement of release rate 
compared to gold nanoparticles and the ability to use longer, less toxic wavelengths 
effectively in nitrobenzyl-based systems. Current results of this comparison study are 
presented, and future in vitro experiments are described. 
3.2. Synthesis and Characterization of Gold and Silver Nanoparticles 
 
The colloidal gold nanoparticle sample of 68 nm diameter (TEM image in (a) of 
Figure 3.1) is prepared using a seeded-growth method where citrate is first used as a 
reducing agent and capping agent for the gold nanoparticle seeds followed by the 
addition of a stronger reducing agent, hydroquinone, to produce larger GNPs with low 
polydispersity. During the gold nanoparticle seed synthesis, 900 µL of 34 mM sodium 
citrate is added to 30 mL of 290 µM gold chloride in ultrapure water under boiling 
conditions with vigorous stirring. The solution changes color to a bright red after 10 
minutes and is then cooled to room temperature. In the second step, 150 µL of the seed 
solution is added to 2.9 mM of gold chloride in 10 mL of ultrapure water, followed by the 
addition of 100 µL of 0.03 M hydroquinone and 22 µL of 34 mM sodium citrate. The 
solution is left to stir at room temperature for 60 min to produce the 68 nm colloidal gold 
nanoparticles. 
For the synthesis of silver nanoparticles (TEM image in (b) of Figure 3.1), 50 ml 
of water in flask with stir bar was first heated to 275 °C. Just before boiling, 100 µL of 
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0.1 M ascorbic acid was added, followed by the addition of a mixture of (250 µL of 1% 
AgNO3, 1000 µL of 1% sodium citrate, and 30 µL of 0.098 mM KI). This mixture is 
prepared 5 minutes before the boiling of water. The resulting mixture is then stirred at 
275 °C for an hour. The synthesis results in 70nm silver nanoparticles with low 
polydispersity.   
 
Figure 3.1. Representative TEM images of GNPs (a) and SNPs (b). 
The surface of the gold and silver nanoparticles are functionalized with 
fluorophore-labeled miRNA via a ‘salt-ageing’ technique as described previously.59 Here, 
2.5 µL of 0.8 µg/µL of the miRNA-148b (PC-miR-148b) modified with the thiolated 
photocleavable nitrobenzyl group and labeled with a 6-TAMRA fluorophore group is 
added to 1 mL of the nanoparticles at concentrations ranging from 10-30 ppm. The mixed 
samples are left to incubate for 24 h under gentle agitation conditions. Following the 
incubation period, 10 µL of 0.035 M sodium dodecyl sulfate (SDS) solution and 20 µL of 
0.01 M phosphate buffer saline solution (PBS) solution are added to each sample. After 
an additional 3 h of incubation, a 10 µL solution of 2 M tris(hydroxymethyl) 
aminomethane (Tris) and 2 M NaCl  is added three times, with 3 h of incubation between 
each salting step. The miRNA-functionalized nanoparticles are purified via centrifugation 
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three consecutive times at 7000 rpm for 20 min each. During the first two centrifugation 
cycles, the precipitate obtained from 1 mL of sample is resuspended in 1 mL of solution 
containing 0.035 M SDS, 0.1 M Tris, 0.103 M NaCl, and 0.0005 M disodium 
diphosphate, and finally in 1 mL of deionized water after the third centrifugation. The 
gold and silver nanoparticles are then characterized using transmission electron 
microscopy (TEM), dynamic light scattering, extinction spectroscopy, and zeta potential 
measurements.  
3.3. SHG Experimental Setup 
 
The experimental setup for the second harmonic generation studies (schematic in 
Figure 3.2), is modified from a previously reported version. The setup uses a 
titanium:sapphire oscillator laser, a titanium:sapphire amplifier laser, an optical 
parametric amplifier (OPA) laser, an optical setup, and a high-sensitivity CCD 
spectroscopy detector. The oscillator laser operates at a center wavelength of 800 nm 
with 75 fs pulses at a repetition rate of 80 MHz and an average power of 2.5 W. A 
beamsplitter separates the oscillator laser beam into one path that is used as the probe 
laser for the SHG measurements and another path that is used to seed the amplifier. A 
portion of the amplifier laser is sent through the OPA to generate the tunable UV or 
visible wavelengths with 100 fs pulses at a repetition rate of 10 kHz. The 800 nm probe 
laser beam for SHG measurements is attenuated to an average power of 790 mW and 
focused to the colloidal sample, which is contained in a 1 cm by 1 cm quartz cuvette at a 
concentration of 8.25 ×109 nanoparticles/mL in water with the SHG collected in the 
forward direction. The wavelength-tunable visible or UV beam for photoactivation is 
directed to the nanoparticle sample at 90° with respect to the 800 nm beam. The SHG 
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from the nanoparticle sample is measured as a function of the UV laser irradiation time 
for investigating photocleaving reaction dynamics from the miRNA-functionalized 
GNPs. A beam block opens and shuts on the photocleaving UV beam every 30 seconds in 
synchronization with an automated file-saving program so that the SHG can be measured 
in real time to monitor the photoactivated drug-delivery reaction. A variable neutral 
density filter is used to control the power of the UV laser. Automated stirring is initiated 
during the UV laser irradiation and is stopped when the UV laser is blocked for stable 
SHG measurements, which are collected at multiple 1 second acquisitions for statistical 
analysis. 
 
Figure 3.2. Diagram of laser setup for SHG experiments 
3.4. Results and Discussion 
 
The light-activated controlled release of oligonucleotides from the surface of gold 
and silver nanoparticles is monitored in real time using second harmonic generation. 
Representative SHG spectra of GNPs, SNPs, miRNA-functionalized GNPs, and miRNA-
functionalized SNPs are shown in this chapter under the same 800 nm laser conditions 
and nanoparticle concentrations. As reported in previous studies, the SHG peak is 
centered at 400 nm with a full width half maximum of 4.5 nm. The larger SHG signal 
from the miRNA-functionalized GNP and miRNA-functionalized SNP samples 
compared to the GNP and SNP samples arise primarily as a consequence of the highly-
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charged miRNA leading to a higher electrostatic surface potential magnitude and a larger 𝜒(!) term in the SHG governing equation, although some added contribution may also 
result from an increased 𝜒(!) term. As before, the 6-TAMRA fluorophore label attached 
to the miRNA is chosen for corresponding fluorescence quantification measurements, 
having minimal absorption at either 800 nm or 400 nm, where no added fluorescence is 
observed in the SHG spectra so the fluorophore is expected to have negligible SHG 
contribution. In each SHG spectra presented, as the UV irradiation time increases, the 
SHG intensity decreases and asymptotically approaches a minimum value. The decrease 
in SHG intensity as a function of UV laser irradiation time is due to the change in the 
surface structure and surface charge leading to a change in the corresponding 𝜒(!) and 𝜒(!)  terms upon photocleaving. The change in the 𝜒(!)  term is expected to be the 
dominant contribution to the change in the SHG signal due to the loss of the high-charged 
miRNA upon photocleaving. 
Figure 3.3 shows a wavelength-dependent study on the photocleaving dynamics 
of miRNA from the nanoparticle surface. In the case of gold, shown in (a) of Figure 3.3, 
when the sample is irradiated with the UV laser at 365 nm, which is on resonance with 
the PC linker, there is a fast decay of the SHG signal, corresponding to a fast rate of 
photocleaving and a large release of miRNA. The decay rate of the SHG signal decreases 
when the UV wavelength is off resonance compared to the PC linker, resulting in a 
slower rate of photocleaving and nucleotide release. The time-dependent SHG intensity 
under the UV irradiation wavelengths of 330 nm, 375 nm, and 415 nm results in slower 
rates of photocleaving in comparison to the 365 nm results, while irradiation at 500 nm 
and 300 nm does not produce any measurable photocleaving. In the case of silver, shown 
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in (b) of Figure 3.3, irradiation with 365 nm laser light produces fastest photocleaving 
and more complete release, while irradiation with 500 nm and 320 nm light produces no 
change in SHG signal. Activation with wavelengths between 330 nm and 460 nm laser 
light produces varying levels of photorelease. Unlike in the case of gold, silver 
nanoparticles produce high levels of photorelease beyond the range of nitrobenzyl 
photocleavage. Near-maximal release was achieved at 365 nm, 375 nm, 435 nm, and 460 
nm. In the above experiments, the UV laser power is kept constant at 20 mW for direct 
comparison of the photocleaving rate at all of these wavelengths. 
 
Figure 3.3. SHG spectra of miRNA photorelease from GNPs (a) and SNPs (b). 
Wavelengths are sampled at constant power (20mW). 
The laser-assisted controlled release of miRNA from the surface of GNPs is 
further analyzed using extinction spectroscopy measurements (Figure 3.4). Figure 3.4 (a) 
shows a significant shift in plasmon peak of the GNPs from 543 nm to 553 nm after 
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functionalization with nucleotides. The extinction spectra is blueshifted after UV laser 
irradiation of the sample compared to the original miRNA-functionalized GNP sample. 
These results further indicate that the oligonucleotides are releasing from the surface of 
GNP upon the UV laser irradiation. Analysis of these measurements demonstrates that 
the extinction spectrum of colloidal GNPs closely matches the extinction spectrum of the 
miRNA functionalized GNP sample after irradiation at 20 mW of 365 nm for 13 min, 
with the plasmon peak blueshifting back to 543 nm. At longer UV irradiation 
wavelengths of 375 nm and 390 nm, under 20 mW for 13 min there is less blueshift in the 
extinction spectra compared to the miRNA-GNPs, going back to plasmon peaks of 545 
nm and 548 nm, respectively, indicating incomplete photocleaving of the miRNA from 
the gold nanoparticle surface.  
Similarly, the laser-assisted controlled release of miRNA from the surface of 
SNPs were analyzed using extinction spectroscopy measurements. Figure 3.4 (b) shows a 
significant shift in plasmon peak of the SNPs from 413 nm to 422 nm after 
functionalization with nucleotides. The blueshift observed after irradiation again indicates 
that miRNA is being released from the SNP surface. Analysis of these measurements 
demonstrates that the extinction spectrum of colloidal SNPs closely matches the 
extinction spectrum of the miRNA functionalized SNP sample after irradiation at 20 mW 
of 365 nm for 13 min, with the plasmon peak blueshifting back to 413 nm, with similar 
results for 20 mW irradiation for 13 minutes at 375 nm and 435 nm. A reduced blueshift 
effect is observed in the extinction spectra of samples irradiated at 20 mW for 13 minutes 
at 300 nm and 500 nm, indicating incomplete photocleaving of the miRNA from the 
silver nanoparticle surface.  
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Figure 3.4. Extinction spectra of unfunctionalized, functionalized, and photocleaved 
miRNA-GNP (a) and miRNA-SNP (b) samples at varying photocleaving wavelengths. 
In order to quantify the photocleaving dynamics, a simple model is described as 
reported previously. SHG is understood to be a coherent process from the surface of each 
individual colloidal nanoparticle, while the overall SHG signal is the incoherent sum of 
the SHG signal from each nanoparticle in the probe laser focus such that the SHG signal 
is linearly proportional to the nanoparticle concentration. Therefore, using the results 
from constant wavelength studies shown in Figure 3.5 (a) and Figure 3.5 (c), the SHG 
electric field can be expressed using the equation 𝐸!"# = 𝐴 + 𝐵[𝐶], where 𝐴 is an offset 
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that includes background signal and the SHG from GNPs and SNPs, [𝐶]  is the 
cumulative concentration of attached miRNA on the GNP or SNP surface, and 𝐵 is a 
proportionality constant. If we assume a single UV photon causes photocleaving from a 
single miRNA attached to the nanoparticle surface with an associated equilibrium 
constant 𝑘, then the change in [𝐶] with respect to time 𝑑[𝐶] 𝑑𝑡 is equal to −𝑘[𝐶][ℎ𝜈], 
where [ℎ𝜈] is the concentration or intensity of UV light. Under constant UV irradiation 
intensity, the time dependence of [𝐶] should follow an exponential decay given by 𝐶 𝑡 =    𝐶 !𝑒!!!! where 𝐶 ! is the initial concentration of attached miRNA on the 
GNP or SNP surface and 𝑘! = 𝑘[ℎ𝜈]. Notice that the pseudo first-order rate constant 𝑘! is 
linearly proportional to the UV light intensity. Under this simple model, assuming the 
photocleaving occurs through a one-photon process, the SHG electric field, which is 
proportional to the square root of the SHG signal, is expected to decay exponentially as a 
function of UV irradiation time, with a rate constant that is linearly proportional to the 
UV laser power.  
In order the test the accuracy of this model, the kinetics of the photocleaving 
process for miRNA-functionalized GNPs are studied using different UV laser powers 
centered at 365 nm. The measured time-dependent SHG electric field from colloidal 
miRNA-functionalized GNP sample under varying UV laser powers is shown in (a) of 
Figure 3.5. Each set of results are fit to a pseudo first-order exponential decay, as 
explained above, for UV laser powers of 35 mW, 45 mW, 55 mW, 75 mW, and 85 mW, 
respectively, to obtain the rate constants 𝑘! of (4.57 ± 0.4) × 10−3 S−1, (6.44 ± 0.4) × 10−3 
S−1, (7.6 ± 0.8) × 10−3 S−1, (9.71 ± 0.6) × 10−3 S−1, and (11.2 ± 0.7) × 10−3 S−1, 
respectively. Figure 3.5 (b) displays these measured rate constants as a function of UV 
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laser power. To compare the photocleaving dynamics of silver to those of gold, the study 
was repeated with miRNA-functionalized SNPs using different laser powers at a constant 
wavelength of 365 nm, as shown in (c) of Figure 3.5. Each set of results are fit to a 
pseudo first-order exponential decay, as explained above, for UV laser powers of 15 mW, 
25 mW, 45 mW, 55 mW, and 75 mW, respectively, to obtain the rate constants 𝑘! of 
(2.45 ± 0.4) × 10−3 S−1, (9.46 ± 0.3) × 10−3 S−1, (21.6 ± 0.1) × 10−3 S−1, (26.2 ± 0.3) × 10−3 
S−1, and (31.2 ± 0.3) × 10−3 S−1, respectively. Figure 3.5 (d) displays these measured rate 
constants as a function of UV laser power. 
 
Figure 3.5. (a) Measured SHG electric field from miRNA-functionalized GNPs as a 
function of irradiation time with 365 nm at different UV laser average powers with 
corresponding exponential fits. (b) The obtained rate constants are plotted as a function of 
UV laser power. The linear variation as a function of laser power indicates a one-photon 
process. (c) Measured SHG electric field from miRNA-functionalized SNPs as a function 
of irradiation time with 365 nm at different UV laser average powers with corresponding 
exponential fits. (b) The obtained rate constants are plotted as a function of UV laser 
power. The linear variation as a function of laser power indicates a one-photon process. 
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Figures 3.6 and 3.7 show comparisons of photorelease kinetics for both SNPs and 
GNPs. Analysis of these results show enhanced photocleavage of miRNA from SNPs. 
Figure 3.6 shows a plot of pseudo-first order rate constants from SNPs and GNPs as a 
function of laser power at 365 nm, showing a significant difference (p < 0.05) between 
the rate at which silver and gold nanoparticles release miRNA by photocleavage.  
 
Figure 3.6. Plot of SNP and GNP photorelease rate constants as a function of UV laser 
average power with linear best fit. Dashed lines represent 95% confidence intervals. 
Using a p-value of <0.05 for significance, the rates are significantly different (p = 
0.0054). 
Figure 3.7 shows photorelease kinetics of silver and gold nanoparticles at 20 mW 
constant power and varying wavelengths. The broad enhancement of miRNA release 
from SNPs indicates that the SNP plasmon (420 nm) is contributing in some way to 
nitrobenzyl photocleaving (most efficient at 365 nm).  
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Figure 3.7. Comparison of rate constants for miRNA-GNPs and miRNA-SNPs as a 
function of wavelength at 20 mW. 
3.5. Conclusions 
 
Second harmonic generation is used to monitor the photo-activated controlled 
release of miRNA from the surface of colloidal gold and silver nanoparticles. Nitrobenzyl 
photocleaving, previously demonstrated to be a one-photon process, is shown to be 
enhanced when using silver nanoparticles instead of gold. This demonstration of 
plasmonic enhancement has important short-term and long-term consequences for 
nanoparticle-based gene delivery. In the short term, the use of silver nanoparticles as 
delivery vehicles allows the cleavage wavelength of the nitrobenzyl group to be tuned 
from 365 nm to less toxic wavelengths up to 460 nm. This increases the clinical viability 
of delivery strategies using this demonstrated photochemical linker. Additionally, this 
work leads to interesting questions in surface plasmon catalysis, including multi-gene 
delivery. Efforts are ongoing to demonstrate plasmonic enhancement in biological 
systems, and additional methods are reported in the appendix. 
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3.6. Materials and Methods 
 
3.6.1. Chemicals and Reagents 
 
For the synthesis of gold nanoparticles, high purity chemicals are purchased from 
Sigma Aldrich, including gold (III) chloride hydrate (99.999%), sodium citrate dihydrate 
(≥ 99%) and hydroquinone (≥ 99%). Ultrapure water having resistivity of >18.2 MΩ is 
used during the synthesis and spectroscopic measurements. Silver nanoparticles are 
synthesized using AgNO3, KI, ascorbic acid, and sodium citrate purchased from Sigma 
Aldrich. Custom thiol-functionalized miRNA-148b is purchased from Trilink Bio 
Technologies. The PBS solution, sodium chloride solid, and dithiothreitol are purchased 
from Sigma Aldrich. Diethylpyrocarbonate (DEPC) water is purchased from Ambion, 
sodium dodecyl sulfate (SDS) from VWR, and tris(hydroxymethyl) aminomethane from 
Amresco.   
3.6.2. Characterizations of Gold and Silver Nanoparticles 
 
The dynamic light scattering and electrophoretic mobilities of the colloidal gold  
and silver nanoparticle samples are obtained using a Malvern Zetasizer (Nano series, 
Malvern Instruments Inc., USA). TEM images of nanoparticles before and after 
functionalization with miRNA are obtained using a high resolution JEOL JEM-2011 
scanning TEM equipped with a Gatan SC1000 CCD camera and an EDAX EDS. 
Extinction measurements are acquired using a Perkin Elmer Lambda 35 UV-Vis 
spectrophotometer. 
3.6.3. Second Harmonic Generation Setup 
 
The ultrafast laser systems used in this study include a Chameleon oscillator laser, 
a Legend Elite amplifier laser, and a TOPAS tunable optical parametric amplifier, which 
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are all purchased from Coherent Inc. The signal detection is achieved using a 
spectrograph/monochromator (Acton SP2300) and CCD detector (PIXIS 400) purchased 
from Princeton Instruments. 
3.6.4. PC-miR-148b Quantification 
 
Oligonucleotide coverage of the gold and silver nanoparticles are quantified using 
fluorescence spectroscopy and inductively coupled plasma optical emission spectroscopy 
(ICP-OES) measurements. PC-miR-148b oligonucleotides from the surface gold 
nanoparticles are cleaved using 1% DTT and the tunable laser irradiation as mentioned 
above. After centrifugation, the supernatant is quantified with fluorimetry using a Wallac 
VICTOR2 V1420-040 Multilabel Counter (Perkin-Elmer, Boston, MA, USA) at 
excitation and emission wavelengths of 531 nm and 572 nm, respectively. The 
concentration of oligonucleotides is calculated using a standardized curve over various 
concentrations of PC-miR-148b. The gold and silver nanoparticle content is quantified 
using ICP-OES (Varian, Palo Alto, CA, USA) after dissolving in 1.6 M nitric acid.  
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4. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
 
4.1. Summary 
 
This thesis has endeavored to describe plasmonic nanodelivery as a technological 
advancement that addresses major concerns in the field of gene delivery. Plasmonic 
nanoparticles are presented as an enabling technology for photoactivated gene delivery, 
based on the need for high spatiotemporal resolution in gene delivery. The ability of 
second harmonic generation spectroscopy (SHG) to precisely measure photorelease 
kinetics of colloidal miRNA-functionalized nanoparticles in real time is an important step 
towards the precise engineering of nanoparticle delivery vehicles. With the convergence 
of genetic research, high precision nanoparticle synthesis, and a growing need for clinical 
approval in the field, SHG spectroscopy could become a crucial characterization 
technique in the pipeline from bench to bedside. Using our SHG techniques, plasmonic 
enhancement is demonstrated in the case of nitrobenzyl photocleavage by the SNP 
plasmon. This discovery opens the door to many interesting physical questions as well as 
applications of plasmon catalysis to differential gene delivery. Based on this goal of 
delivering multiple genes in the same tissue volume, several key experiments and 
applications are described as well.  
4.2. Conclusions 
 
We used second harmonic generation (SHG) spectroscopy to monitor the light-
activated controlled release of oligonucleotides from the surface of colloidal gold 
nanoparticles. MicroRNA is functionalized to spherical gold nanoparticles using a 
nitrobenzyl linker that undergoes photocleaving upon ultraviolet irradiation. The SHG 
signal generated from the colloidal nanoparticle sample is shown to be a sensitive probe 
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for monitoring the photocleaving dynamics in real time. The photocleaving irradiation 
wavelength is scanned to show maximum efficiency on resonance at 365 nm and the 
kinetics are investigated at varying irradiation powers to demonstrate that the nitrobenzyl 
photocleaving is a one-photon process. Additional characterization methods including 
electrophoretic mobility measurements, extinction spectroscopy, and fluorimetry are used 
to verify the SHG results, leading to a better understanding of the photocleaving 
dynamics for this model oligonucleotide therapeutic delivery system.  
Additionally, second harmonic generation spectroscopy is used to compare 
miRNA-functionalized GNPs with miRNA-functionalized SNPs. Real-time colloidal 
SHG measurements are reported for nitrobenzyl photocleavage, and are used to generate 
power and wavelength-based measurements of photorelease kinetics. Analysis of 
photorelease kinetics shows a significant increase in release efficiency on miRNA-SNPs, 
owing to the proximity of the SNP plasmon to the nitrobenzyl photocleavage peak. 
Plasmonic catalysis is proposed as the explanation for this enhancement, demonstrating a 
new way of thinking about efficient gene delivery, and applications, improvements, and 
further studies are suggested.  
4.3. Recommendations for Future Research 
 
4.3.1. Elucidation of Plasmonic Photocatalysis Mechanisms 
 
The results presented in this study open the door for the study of even more 
interesting questions beyond the scope of this thesis. Many of them apply to the 
fundamental physics and chemistry of these nanoparticle constructs. Regarding plasmon 
catalysis of nitrobenzyl photocleavage, there is a great deal to be learned from a search to 
understand the mechanism by which the plasmon catalyzes this reaction. In the literature, 
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most plasmon catalyzed reactions proceed via oxidation or reduction reactions, mediated 
either by hot electrons or by plasmonic heating.137-138, 140-141, 143 However, the results 
presented here may demonstrate the influence of plasmonic catalysis in a more traditional 
photochemical reaction. The apparent dependence on plasmon wavelength, coupled with 
the larger distance from the particle surface may point to a different mechanism of 
plasmon catalysis that can be applied to other problems in photocatalysis.  
In the field of surface plasmon assisted catalysis (SPAC) chemistry, mechanisms 
of release are spatially dependent. In theory, it is possible to tune the mechanism by 
which the reaction is catalyzed by tuning the length between the photocleavable linker 
and the nanoparticle surface. Some groups have approached this challenge by producing 
nanoparticles with controlled layers of insulating material.137 However, the nature of the 
miRNA-photolinker construct is such that we can change the length of the alkane thiol 
spacer with the same effect. Another question revolves around whether the observed 
SPAC effect in the case of nitrobenzyl photocleaving is assisted via plasmonic heating or 
if there is a transfer of electrons between the particle and the nitrobenzyl group.   
These questions are typically studied using surface enhanced Raman spectroscopy 
(SERS) or tip-enhanced Raman spectroscopy (TERS). In most cases, these studies 
require nanoparticles to be dispersed on a substrate, which changes the optical response 
of the nanoparticle constructs relevant to colloidal solution. However, our experience in 
nonlinear ultrafast spectroscopies may yield a complementary measurement technique to 
Raman-based techniques and SHG spectroscopy. Transient absorption (TA) spectroscopy 
provides a means to study the dynamics of charge carriers within the colloidal 
nanoparticle solutions.144-147 TA relies on similar experimental conditions to SHG, 
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allowing us to quickly transition from an SHG result to an in-depth exploration of charge 
carrier dynamics. These charge carrier dynamics studies will provide very useful 
information for the design of future photocleavable chemistries.  
4.3.2. Design of Nanoparticles and Photochemistries for Plasmonic Delivery 
 
A primary objective of plasmonic gene delivery is to control the release of 
multiple genes in the same tissue volume. Our recent results demonstrating a role for 
plasmon catalysis in miRNA photorelease are an indication that the plasmonic properties 
of noble metal nanoparticles could provide a platform for selective release of multiple 
genes from mixed colloidal solutions. Two technical achievements will provide 
confirmation that such an approach is a plausible solution to the challenge of controlling 
multi-gene delivery. First, SHG experiments must be conducted on controlled mixtures of 
silver nanoparticles and gold nanoparticles in order to resolve the two materials in a 
mixed spectrum. If these nanoparticle mixtures can be effectively characterized, studying 
the release of two miRNAs will not require the development or implementation of new 
analysis methods. The second technical goal of this work is the implementation of a 
wavelength-independent photocleavable chemistry. This work is currently under progress 
in our group and is showing promising result using reverse Diels-Alder chemistry. The 
combination of SHG spectroscopy measurements capable of resolving the signal of gold 
and silver nanoparticles and a wavelength-independent photochemistry will provide an 
ideal starting point for the development of a multi-gene delivery platform.  
Building upon an initial proof of concept, nanoparticle syntheses can be further 
engineered to modulate the plasmon wavelength in the pursuit of enhanced plasmonic 
activity and multiple distinguishable peaks to achieve the delivery or more than two 
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genes within the same tissue volume. Choice of nanoparticle material, core-shell 
structure, and magnetic properties can provide these enhanced capabilities. Building on 
the foundation of silver and gold nanoparticles, other metal nanoparticles can be 
incorporated into a multi-gene delivery scheme based on their plasmon wavelengths. In 
the literature, platinum is reported to be biocompatible with a wavelength in the UV 
range. Because of tissue penetration depth, however, additional particles with redshifted 
activation wavelengths would be more clinically applicable than UV-activated platinum 
nanoparticles. Alloy nanoparticles provide an interested means of accessing the 
wavelengths between the silver and gold plasmon wavelengths. Results from literature 
demonstrate that plasmon wavelength can be controlled by the ratio of gold to silver salts 
used in the synthesis. Alloy nanoparticles could provide an input wavelength between 
that of silver and gold nanoparticles that could allow for the selective release of three or 
more miRNAs in the same tissue volume. Further towards the near-infrared range, core-
shell nanoparticles could provide more input options, plasmon enhancement, and deeper 
tissue penetration. A search of the literature reveals many options for core-shell 
nanoparticle synthesis, including silver-gold, silver-silica, gold-silica, and gold-iron 
oxide. Especially interesting is the ability to incorporate iron oxide into a core-shell 
synthesis in order to provide clinicians with the ability to image and control the 
nanoparticles with magnetic fields provided by magnetic resonance or other types of 
magnetic imaging common in the healthcare industry.  
4.3.3. Applications of Differential Multi-gene Delivery 
 
After developing the nanophysics and photochemistry behind this delivery 
strategy, it is necessary to develop a model system for the study of multi-gene delivery 
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and apply those results to clinical challenges in gene therapy and regenerative medicine. 
The breadth and pace of research into miRNA and the various pathways they influence 
requires the development of a model system for the study of plasmonic multi-gene 
delivery that allows for simple testing and optimization of the nanoparticles, 
photocleavable linkers, and other system components. Designing a stable line of tumor 
cells that express both green fluorescent protein (GFP) and red fluorescent protein (RFP) 
would allow for the study of dual oligonucleotide release in a system that is easy to 
predict and quantify. Once plasmonic multi-gene delivery is proven in an RFP/GFP 
system in vitro, work will shift to applications in stem cell differentiation and 
regenerative medicine. The ideal application will have clinical impact, be mediated by 
miRNA pathways, and have some component requiring spatiotemporal resolution. 
One particular application of interest is the transdifferentiation of adipocytes for 
the treatment of obesity-related conditions. The literature describes three types of adipose 
cells that are categorized according to morphology, origin, and function (Figure 4.1).148  
 
Figure 4.1. Figure depicting the origins and pathways of white, brown, and beige 
adipocytes. Figure from Seal and Harms, 2013. 
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White adipose tissue (WAT) cells with a single, large lipid vesicle that function in 
energy storage, and in excess, contribute to obesity. Brown adipose tissue (BAT) cells are 
composed of smaller lipid vesicles and function primarily in non-shivering 
thermogenesis.28, 31, 33, 60, 149-151 Developmentally encoded BAT results from Myf5+ 
precursor cells, while WAT results from Myf5- precursor cells. The activity of 
developmentally encoded BAT has been shown to depend on obesity level and frequency 
of exercise (Figure 4.2), and these deposits can be further activated by cold exposure 
(Figure 4.3).152  
 
Figure 4.2. Brown adipose tissue in adult humans imaged by PET-CT scanning with an 
18F-fluorodeoxyglucose probe. Row A shows 3 lean adults with high activity levels, row 
B shows 3 lean individuals with low to moderate activity levels, and row C shows obese 
individuals. Figure from Lichtenbelt, et al., 2009. 
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However, one of the most exciting discoveries in the field of BAT biology is that 
WAT can be converted into brown-like “beige” adipocytes. Although important studies 
are still underway, it is believed that beige adipocytes have no functional difference from 
classical brown adipocytes.149, 151, 153-155 The ability to convert energy storing cells into 
energy burning cells would be a paradigm-shifting advance in the treatment of obesity. 
 
Figure 4.3. Activation of BAT by cold exposure imaged by 18F-fluorodeoxyglucose 
PET-CT. Figure from Lichtenbelt, et al., 2009. 
Many important studies have been conducted on BAT and the “browning” 
transformation of WAT to beige adipose tissue, leading to two conclusions that point to 
the applicability of this process to our work in plasmon-enhance differential gene 
delivery. First, the natural spatial divisions of subcutaneous and intra-abdominal WAT as 
well as constitutive and induced BAT deposits provide a need for optimal spatial control 
of delivery. The gradients present in the neck, chest, and pelvic areas provide ample 
opportunity to test the limits of the in vivo spatiotemporal resolution of our system.  
Secondly, the adipocyte browning process and adipogenesis itself are regulated 
through a number of well-studied miRNA pathways (Figure 4.4).13, 29, 31-33, 60, 156 This 
provides the opportunity to study combinatorial treatment options such as synergism, 
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antagonism, or co-regulation, as well as the ability to control the behavior of WAT and 
BAT cells in the same tissue volume.  
 
Figure 4.4. Summary figure of miRNA implicated in adipogenesis. Figure from Arner, et 
al., 2015. 
The combination of an active role for multiple miRNAs in adipogenesis and 
browning, along with the inherent spatial component of adipose distribution make this an 
ideal system for the implementation of our proposed system of selective spatiotemporal 
control of gene delivery using plasmonic nanoparticles  
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APPENDIX: BIOLOGICAL ASSAYS AND CONTROL EXPERIMENTS 
 
This appendix contains methods used to quantify the biological effect of 
plasmonic gene delivery and further study the effect of the nanoparticle plasmon on 
photorelease. Contained here are proposals for nonplasmonic control experiments, to 
determine the effect of non-metallic particles on photorelease, as well as a battery of 
biological assays modified from previous work in our laboratory, including confocal 
microscopy, histochemical staining, quantitative real-time polymerase chain reaction (Q-
PCR), and osteocalcin enzyme-linked immunosorbent assay (ELISA). These tests are 
currently optimized for osteogenesis, based on our study of miRNA-148b, and would 
need to be modified with new stains and targets for adipose-related work.  
An important step towards fuurther confirmation of plasmon photocatalyzed 
miRNA delivery is the development of appropriate non-plasmonic controls. To this end, 
the author proposes the use of 80 nm amine-functionalized silica nanoparticles 
(NanoComposix, San Diego, CA, USA) as a control nanoparticle. Silica nanoparticles 
can be functionalized by linking the amine group to the thiol group of the photocleavable 
oligo construct via a Succinimidyl trans-4-(maleimidylmethyl)cyclohexane-1-
Carboxylate (SMCC) linker (Life Technologies). For Mander’s coefficient studies, it is 
necessary to functionalize the particle with a non-overlapping fluorophore that can be 
imaged with the TAMRA attached to the miRNA. The author proposes accomplishing 
this synthesis by first reacting the aminated nanoparticles with a low concentration of an 
amine-reactive fluorescein dye and then proceeding with the SMCC and miRNA 
addition.  
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Mander’s coefficient is an image processing method used to quantify 
colocalization. To measure release of miRNA within the cell, slides are prepared after 
incubation with miRNA nanoparticles and exposed to 365 nm light. A confocal 
microscope is used, with channels dedicated to measuring the TAMRA fluorophore and 
the nanoparticle reflectance, which can be overlaid to generate a Mander’s coefficient for 
a given set of experimental conditions. If using comparable particle and oligo 
concentrations, it is expected that silver will require less energy to reach full release.  
Confocal microscopy was used to monitor in vitro photorelease of PC-mir-148b 
from the nanoparticles. To prepare samples for microscopy, hASCs were seeded in 1.0 
Borosilicate cover glass Lab-Tek 8-well chambered slides (Thermo Fisher Scientific, 
Rochester, NY) treated with PC-miR-148b-NPs and incubated for 24 hours. Similarly 
cells were flashed for 5 min at 365 nm, 4 h prior to imaging (20 h post-PC-miR-148b-
SNP conjugate delivery). Samples were fixed with 4% formaldehyde in Dulbecco’s 
Phosphate-Buffered Saline (DPBS) for 1- 2 min and rinsed with DPBS prior to imaging. 
The Leica TCS SP2 spectral confocal and multiphoton system used consists of a Leica 
DM IRE2 inverted microscope with a galvo-Z stage. Excitation lasers at 488 and 543 nm 
were used in imaging experiments, concurrently with tuned emission wavelength 
windows. Reflectance mode images of SNPs and GNPs (488/492 nm) and 6-TAMRA 
labeled PC-miR-148b fluorescence (543/572 nm) were overlaid to visualize the co-
localization difference between the radiated and non-radiated samples. Images were 
analyzed using Leica Confocal Software (LCS) Lite (Leica Microsystems Heidelberg 
GmbH).  
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Alkaline phosphatase (ALP) histochemistry are to be performed on hASCs 
exposed to different treatments of silver or gold nanoparticles on day 7. Qualitative (SCR 
004) and quantitative (SCR 066) Millipore kits are used to measure the ALP upregulation 
according to the manufacturer’s instructions. To prepare the stain, hASCs are fixed with 
4% formaldehyde in Dulbecco’s Phosphate-Buffered Saline (DPBS) for 1- 2 min and 
then rinsed DPBS. Fast Red Violet solution and Napthol AS-BI phosphate solution are 
used to stain the cells. Stained cells are imaged with a color camera mounted on Olympus 
cell TIRF illuminator light microscope.  For quantitative ALP measurement, cells were 
isolated from each sample and reacted with p-nitrophenylphosphate (p-NPP) substrate 
according to instructions provided in the kit. The absorbance of p-nitrophenol was 
measured at 405 nm with Wallac VICTOR2 V1420-040 Multilabel Counter. To 
normalize the measurement, total cell counts were taken using a PicoGreen assay (Life 
Technologies, Eugene, OR) at 7 days. 
 For Alizarin Red (ARS) histochemical staining of mineralized matrix, the 
cultured hASCs were stained on day 14. After the media was removed, hASCs were 
rinsed with DPBS before staining with 2% Alizarin Red (2 g/100 ml DI water, pH 
adjusted to 4.1 by adding 10% ammonium hydroxide) for 10 min. The cells are then 
washed with DPBS six times before imaging on with an Olympus TIRF light microscope. 
Mineralization of hASCs with photoactivated PC-miR-148b-NPs was quantified by 
destaining the cells at room temperature by adding 400 ml of 10% cetylpyridinium 
chloride monohydrate to each well followed with shaking for 10 min. Calcium deposition 
is measured as a function of the optical density of the aliquots measured at 540 nm with a 
   70 
plate reader and normalized to number of hASCs, measured by PicoGreen (Life 
Technologies, Eugene, OR) at 14 days. 
Total RNA was extracted from injected/transfected hASCs with Tri Reagent 
according to the manufacturer’s instructions. The extracted RNA was then used to 
perform Q-PCR with iScript One-Step RT-PCR Kit with SYBR Green using 
MiniOpticon Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA). 
The sequences of PCR primers (forward and backward, 5’ – 3’) used to assess the 
osteogenic differentiation of hASCs with nanoparticles were as follows: ALP, 
5’AATATGCCCTGGAGCTTCAGAA3’ and 5’CCATCCCATCTCCCAGGAA3’; 
osteocalcin (OCN), 5’GCCCAGCGGTGCAGAGT3’ and 
5’TAGCGCCTGGGTCTCTTCAC3’ and RunX2; 
5’GCAAGGTTCAACGATCTGAGATT3’ and 
5’AGACGGTTATGGTCAAGGTGAAA3’ . Samples were normalized (ΔCt) against the 
house keeping gene 18s rRNA and -ΔΔCt value of ALP, OCN and RunX2 in hASCs, 
relative to SM, was calculated using the ΔΔCt method 
According to previously published methods, to evaluate OCN levels in the hASCs 
treated with PC-miR-148-NPs (radiated and non-radiated) along with other controls 
mentioned previously for 14 or 28 days. The cell media of last four days for each sample 
was collected and tested for OCN secretion using a commercially available kit (Life 
Technologies, Grand Island, NY). The media was incubated with microplate coated with 
osteocalcin antibody before introducing anti-osteocalcin horseradish peroxidase (HRP) 
conjugate. The plate was then washed, incubated with chromogen (tetramethylbenzidine) 
and stopping reagent respectively. The product was measured at 450 nm, and the amount 
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of OCN was quantified with a standard curve and then normalized to number of hASCs 
measured by PicoGreen (Life Technologies, Eugene, OR), at 14 and 28 days respectively.  
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